volume 25 issue 1 pages 9-21

Perspective: the potential of pyrazole-based compounds in medicine

Frankline K Keter 1
James Darkwa 2
Publication typeJournal Article
Publication date2011-10-15
scimago Q1
wos Q2
SJR0.785
CiteScore7.7
Impact factor3.6
ISSN09660844, 15728773
Metals and Alloys
General Biochemistry, Genetics and Molecular Biology
Biomaterials
General Agricultural and Biological Sciences
Abstract
Pyrazoles are widely used as core motifs for a large number of compounds for various applications such as catalysis, agro-chemicals, building blocks of other compounds and in medicine. The attractiveness of pyrazole and its derivatives is their versatility that allows for synthesis of a series of analogues with different moieties in them, thus affecting the electronics and by extension the properties of the resultant compounds. In medicine pyrazole is found as a pharmacophore in some of the active biological molecules. While pyrazole derivatives have been extensively studied for many applications including anticancer, antimicrobial, anti-inflammatory, antiglycemic, anti-allergy and antiviral, much less has been reported on their metal counterparts in spite of the fact that metals have been shown to impart activity to ligands. Thus this perspective is intended to demonstrate the potential of pyrazole and pyrazolyl metal complexes in the areas of drug discovery and development. Several examples, that include palladium, platinum, copper, gold, zinc, cobalt, nickel, iron, copper, silver and gallium complexes, are used to bolster the above point. For the purposes of this review three areas are discussed, that is pyrazole metal complexes as: (i) anticancer, (ii) antibacterial/parasitic and (iii) antiviral agents.
Found 
Found 

Top-30

Journals

1
2
3
4
5
6
7
8
9
Journal of Molecular Structure
9 publications, 4.27%
Polyhedron
8 publications, 3.79%
European Journal of Medicinal Chemistry
7 publications, 3.32%
ChemistrySelect
7 publications, 3.32%
Journal of Heterocyclic Chemistry
7 publications, 3.32%
Organic Letters
7 publications, 3.32%
Applied Organometallic Chemistry
5 publications, 2.37%
RSC Advances
5 publications, 2.37%
New Journal of Chemistry
5 publications, 2.37%
Organic and Biomolecular Chemistry
4 publications, 1.9%
Journal of Organometallic Chemistry
4 publications, 1.9%
Journal of Organic Chemistry
4 publications, 1.9%
ACS Omega
4 publications, 1.9%
Journal of Coordination Chemistry
4 publications, 1.9%
Transition Metal Chemistry
3 publications, 1.42%
Medicinal Chemistry Research
3 publications, 1.42%
Spectrochimica Acta - Part A: Molecular and Biomolecular Spectroscopy
3 publications, 1.42%
Bioorganic Chemistry
3 publications, 1.42%
Coordination Chemistry Reviews
3 publications, 1.42%
European Journal of Organic Chemistry
3 publications, 1.42%
Inorganic Chemistry
3 publications, 1.42%
Letters in Organic Chemistry
2 publications, 0.95%
Current Green Chemistry
2 publications, 0.95%
Applied Sciences (Switzerland)
2 publications, 0.95%
International Journal of Molecular Sciences
2 publications, 0.95%
Research on Chemical Intermediates
2 publications, 0.95%
Molecular Diversity
2 publications, 0.95%
Inorganic Chemistry Communication
2 publications, 0.95%
Journal of Inorganic Biochemistry
2 publications, 0.95%
Bioorganic and Medicinal Chemistry Letters
2 publications, 0.95%
1
2
3
4
5
6
7
8
9

Publishers

10
20
30
40
50
60
70
Elsevier
61 publications, 28.91%
Wiley
43 publications, 20.38%
American Chemical Society (ACS)
21 publications, 9.95%
Springer Nature
20 publications, 9.48%
Royal Society of Chemistry (RSC)
20 publications, 9.48%
Taylor & Francis
8 publications, 3.79%
Bentham Science Publishers Ltd.
7 publications, 3.32%
MDPI
7 publications, 3.32%
Pleiades Publishing
4 publications, 1.9%
Georg Thieme Verlag KG
4 publications, 1.9%
International Union of Crystallography (IUCr)
3 publications, 1.42%
Beilstein-Institut
1 publication, 0.47%
AIP Publishing
1 publication, 0.47%
Canadian Science Publishing
1 publication, 0.47%
Institution of Engineering and Technology (IET)
1 publication, 0.47%
Pharmaceutical Society of Japan
1 publication, 0.47%
IOP Publishing
1 publication, 0.47%
King Saud University
1 publication, 0.47%
The Japan Institute of Heterocyclic Chemistry
1 publication, 0.47%
Walter de Gruyter
1 publication, 0.47%
Asian Journal of Chemistry
1 publication, 0.47%
Akademizdatcenter Nauka
1 publication, 0.47%
Naksh Solutions
1 publication, 0.47%
10
20
30
40
50
60
70
  • We do not take into account publications without a DOI.
  • Statistics recalculated weekly.

Are you a researcher?

Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
211
Share
Cite this
GOST |
Cite this
GOST Copy
Keter F. K., Darkwa J. Perspective: the potential of pyrazole-based compounds in medicine // BioMetals. 2011. Vol. 25. No. 1. pp. 9-21.
GOST all authors (up to 50) Copy
Keter F. K., Darkwa J. Perspective: the potential of pyrazole-based compounds in medicine // BioMetals. 2011. Vol. 25. No. 1. pp. 9-21.
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.1007/s10534-011-9496-4
UR - https://doi.org/10.1007/s10534-011-9496-4
TI - Perspective: the potential of pyrazole-based compounds in medicine
T2 - BioMetals
AU - Keter, Frankline K
AU - Darkwa, James
PY - 2011
DA - 2011/10/15
PB - Springer Nature
SP - 9-21
IS - 1
VL - 25
PMID - 22002344
SN - 0966-0844
SN - 1572-8773
ER -
BibTex |
Cite this
BibTex (up to 50 authors) Copy
@article{2011_Keter,
author = {Frankline K Keter and James Darkwa},
title = {Perspective: the potential of pyrazole-based compounds in medicine},
journal = {BioMetals},
year = {2011},
volume = {25},
publisher = {Springer Nature},
month = {oct},
url = {https://doi.org/10.1007/s10534-011-9496-4},
number = {1},
pages = {9--21},
doi = {10.1007/s10534-011-9496-4}
}
MLA
Cite this
MLA Copy
Keter, Frankline K., and James Darkwa. “Perspective: the potential of pyrazole-based compounds in medicine.” BioMetals, vol. 25, no. 1, Oct. 2011, pp. 9-21. https://doi.org/10.1007/s10534-011-9496-4.